SCHEMBL462893

SCHEMBL462893

C=CCOC(=O)C1(C)Cc2ccccc21

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.49
ALDH1A1 P00352 3/20 0.47
MAPT P10636 3/20 0.40
TSHR P16473 1/20 0.40
HSD17B10 Q99714 1/20 0.40
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39
RHOA P61586 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
BRD4 O60885 1/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
KDM4E B2RXH2 1/20 0.37
LMNA P02545 1/20 0.37
GAA P10253 1/20 0.37
MAPK1 P28482 1/20 0.37
PKM P14618 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
CXCR5 P32302 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27188909 0.82 CYP3A4 (0.45) CYP3A4ALDH1A1MAPTTSHRHSD17B10
SCHEMBL547428 0.78 MEN1 (0.44) ALDH1A1MAPTMEN1KMT2ALMNA
SCHEMBL18101494 0.76 SMN1; SMN2 (0.45) CYP3A4ALDH1A1MAPTTSHRHSD17B10
SCHEMBL18101499 0.73 CYP3A4 (0.38) CYP3A4ALDH1A1MAPTTSHRHSD17B10
SCHEMBL3136514 0.72 ALDH1A1 (0.40) ALDH1A1LMNA
SCHEMBL14214940 0.70 HDAC9 (0.47) CYP3A4ALDH1A1MAPTTSHRHSD17B10
SCHEMBL9405305 0.70 CA1 (0.45) CYP3A4ALDH1A1MAPTTSHRHSD17B10
SCHEMBL1654890 0.69 ALDH1A1 (0.43) CYP3A4ALDH1A1MAPTTSHRHSD17B10
SCHEMBL7196359 0.68 CYP3A4 (0.42) CYP3A4ALDH1A1MAPTTSHRHSD17B10
Ethane SCHEMBL28085459 0.67 CYP3A4 (0.92) CYP3A4ALDH1A1MAPTTSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3181550-B1 BENZOCYCLOALKENES AS ANTIFUNGAL AGENTS BAYER IP GMBH (DE) 2019-11-20 EP disclosed
EP-3181550-A1 BENZOCYCLOALKENES AS ANTIFUNGAL AGENTS Bayer Intellectual Property GmbH (DE) 2017-06-21 EP disclosed
US-20160023987-A1 BENZOCYCLOALKENES AS ANTIFUNGAL AGENTS BAYER INTELLECTUAL PROPERTY GMBH (DE) 2016-01-28 US disclosed
US-9173399-B2 Benzocycloalkenes as antifungal agents BAYER INTELLECTUAL PROPERTY GMBH (DE) 2015-11-03 US disclosed
EP-2595961-A2 BENZOCYCLOALKENES AS ANTIFUNGAL AGENTS Bayer Intellectual Property GmbH (DE) 2013-05-29 EP disclosed
US-20130123322-A1 BENZOCYCLOALKENES AS ANTIFUNGAL AGENTS BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-05-16 US disclosed
WO-2012010579-A2 BENZOCYCLOALKENES AS ANTIFUNGAL AGENTS BAYER CROPSCIENCE AG (DE) 2012-01-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160023987-A1 BENZOCYCLOALKENES AS ANTIFUNGAL AGENTS CYP51A1, ERG28, CBR1 CYP3A4 30/4885ALDH1A1 2101/4885MAPT 3160/4885
US-20130123322-A1 BENZOCYCLOALKENES AS ANTIFUNGAL AGENTS CYP51A1, ERG28, CBR1 CYP3A4 30/4885ALDH1A1 2101/4885MAPT 3160/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.